Dual GIP/GLP-1 agonists

1 trial
  • 2021SURPASS-2Head-to-head vs semaglutideIn 1,879 patients with T2DM on metformin, tirzepatide 5, 10 or 15 mg weekly reduced HbA1c and body weight more than semaglutide 1 mg weekly.